PDCD1 and melanoma: In cancer, the dysregulation of the PD-1/PD-L1 axis enables cancer cells to evade the immune system, and the overexpression of PD-L1 is associated with poor prognosis in patients with melanoma, lung, and ovarian cancers [13, 22].